Health

Does getting COVID make you more likely to develop dementia?

If true, it has great implications both for individuals and for society as a whole. There are around 400,000 Australians are already living with dementia – and that number is expected to reach around 850,000 by 2058. Even a small increase in dementia risk could mean tens of thousands more Australians are living with the …

Does getting COVID make you more likely to develop dementia? Read More »

New drug could turn Covid virus against itself and fight variants

New Delhi: US scientists have developed a new drug that can turn SARS-CoV-2 against itself and prevent death virus to infect humans. Researchers at the Scripps Research Institute believe the drug, called NMT5, is likely to be effective against emerging variants of SARS-CoV-2. ADVERTISING CONTINUE READING BELOW The drug, described in the journal Nature Chemical …

New drug could turn Covid virus against itself and fight variants Read More »

Alzheimer’s dementia risk can be predicted using a new tool

Using demographic information, brain imaging test results and genetic biomarkers, researchers at Washington University School of Medicine in St. Louis have developed an algorithm that can help provide people who volunteer for studies on aging information on the risk everyone faces of developing dementia due to Alzheimer’s disease. Published September 30 in the Journal of …

Alzheimer’s dementia risk can be predicted using a new tool Read More »

Study: The structure of monkeypox virus 2’-O-ribose methyltransferase VP39 in complex with sinefungin provides the foundation for inhibitor design. Image Credit: Marina Demidiuk/Shutterstock

Structural analysis of monkeypox virus to guide the development of broad antiviral agents

In a recent study published on bioRxiv* preprint server, researchers explored the crystal structure of monkeypox virus (MPX) (MPXV) and the complex of VP39, a 2′-O-RNA methyltransferase (MTase) and sinefungin, a pan-MTase inhibitor . Study: The structure of monkeypox virus 2′-O-ribose methyltransferase VP39 in complex with sinefungin forms the basis for the design of the …

Structural analysis of monkeypox virus to guide the development of broad antiviral agents Read More »

Human Brain Project researchers identify new marker of ALS outcomes

A study by researchers from the Human Brain Project (HBP) has identified a new marker that can predict the clinical course of patients with amyotrophic lateral sclerosis (ALS) using magnetoencephalography. This marker can be measured in the brain during its resting state and highlights the importance of cerebral flexibility for ALS patients. The study was …

Human Brain Project researchers identify new marker of ALS outcomes Read More »

Research supports link between inflammation and cognitive problems in older breast cancer survivors

LOS ANGELES — Scientists are still trying to figure out why many breast cancer survivors experience troubling cognitive issues for years after treatment. Inflammation is a possible culprit. A new long-term study of elderly breast cancer survivors published today in the Journal of Clinical Oncology and co-led by UCLA researchers adds important evidence to this …

Research supports link between inflammation and cognitive problems in older breast cancer survivors Read More »

Human Brain Project researchers identify new marker of ALS outcomes

Material used in the study. Credit: Arianna Polverino, Parthenope University, Naples A study by researchers from the Human Brain Project (HBP) has identified a new marker that can predict the clinical course of patients with amyotrophic lateral sclerosis (ALS) using magnetoencephalography. This marker can be measured in the brain during its resting state and highlights …

Human Brain Project researchers identify new marker of ALS outcomes Read More »